title: Acute lymphoblastic leukemia developing during maintenance therapy with lenalidomide in a patient with multiple myeloma.
authors.affiliation: Hematology Service, Hospital San Pedro , Logroño, La Rioja , Spain.
authors.forename: Ricardo
authors.initials: R
authors.lastname: García-Muñoz
authors.forename: Diego
authors.initials: D
authors.lastname: Robles-de-Castro
authors.forename: Aura
authors.initials: A
authors.lastname: Muñoz-Rodríguez
authors.forename: Pilar
authors.initials: P
authors.lastname: Rabasa
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D000077269:Lenalidomide; D060046:Maintenance Chemotherapy; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000209:etiology*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014182:Transplantation, Autologous
chemical_list: D000970:Antineoplastic Agents; D007155:Immunologic Factors; D013792:Thalidomide; D000077269:Lenalidomide